Who invested in Lung Therapeutics?
Lung Therapeutics's investors include UT Horizon Fund, Texas Venture Labs, Bios Partners and Bios Partners/ UT Horizon Fund.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$52Mraised across 5 rounds since 2013, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $14M sold, first sale Mar 2016
From a historical funding recordSEC filing: $1.6M sold, first sale Sept 2014
From the SEC filings it signed: 2 on the team.
On the board, as filediAaron G.L. FletcherWilliam C. Fairey
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Lung Therapeutics's investors include UT Horizon Fund, Texas Venture Labs, Bios Partners and Bios Partners/ UT Horizon Fund.
Lung Therapeutics has raised $52M across 5 rounds since 2013. 2 rounds did not disclose an amount, so the total is a floor.
Lung Therapeutics's most recent round was a Series C of $36M in Jun 2019.
Its most recent round, $36M in Jun 2019, is also its largest on record.
Lung Therapeutics's first round on record, in Jul 2013, was backed by UT Horizon Fund.
Lung Therapeutics's latest named round is a Series C, in Jun 2019.
Lung Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.